Costakis Frangou

612 total citations
7 papers, 443 citations indexed

About

Costakis Frangou is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Costakis Frangou has authored 7 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Costakis Frangou's work include Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Biochemical and Molecular Research (2 papers). Costakis Frangou is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Biochemical and Molecular Research (2 papers). Costakis Frangou collaborates with scholars based in United States, Netherlands and India. Costakis Frangou's co-authors include Matthias Herrmann, Geoffrey M. Wahl, Randall E. Morris, Bernhard J. Kirschbaum, Robert I. Fox, Vibeke Strand, Jianmin Wang, Lori Shepherd, Erik S. Knudsen and Nuo Yang and has published in prestigious journals such as Nature Communications, Cancer Research and eLife.

In The Last Decade

Costakis Frangou

7 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Costakis Frangou United States	7	165	140	74	74	65	7	443
Daniel Torres‐Moreno Spain	12	114 0.7×	64 0.5×	89 1.2×	112 1.5×	97 1.5×	24	399
Carole Ferraro France	5	160 1.0×	116 0.8×	41 0.6×	83 1.1×	157 2.4×	5	510
Caterina Baldi Italy	10	92 0.6×	158 1.1×	63 0.9×	42 0.6×	100 1.5×	52	423
M Dimitrijevic Serbia	9	135 0.8×	175 1.3×	82 1.1×	58 0.8×	111 1.7×	18	525
William Koss United States	9	139 0.8×	59 0.4×	50 0.7×	157 2.1×	33 0.5×	19	426
Taher E. Taher United Kingdom	15	123 0.7×	190 1.4×	80 1.1×	92 1.2×	405 6.2×	23	669
Noria Harir Algeria	10	178 1.1×	56 0.4×	35 0.5×	164 2.2×	174 2.7×	37	514
Tess Schmalbach United States	10	114 0.7×	41 0.3×	54 0.7×	99 1.3×	148 2.3×	24	446
Slah Ouerhani Tunisia	15	335 2.0×	79 0.6×	54 0.7×	100 1.4×	27 0.4×	49	554
Rachel Audo France	15	271 1.6×	191 1.4×	38 0.5×	102 1.4×	347 5.3×	27	662

Countries citing papers authored by Costakis Frangou

Since Specialization

Citations

This map shows the geographic impact of Costakis Frangou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costakis Frangou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costakis Frangou more than expected).

Fields of papers citing papers by Costakis Frangou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costakis Frangou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costakis Frangou. The network helps show where Costakis Frangou may publish in the future.

Co-authorship network of co-authors of Costakis Frangou

This figure shows the co-authorship network connecting the top 25 collaborators of Costakis Frangou. A scholar is included among the top collaborators of Costakis Frangou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costakis Frangou. Costakis Frangou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kumarasamy, Vishnu, Michelle Roti, John Bisi, et al.. (2025). Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. Nature Communications. 16(1). 1476–1476. 8 indexed citations

2.

Kumarasamy, Vishnu, Costakis Frangou, Prasenjit Dey, et al.. (2024). The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. Cancer Research. 84(7). 1115–1132. 19 indexed citations

3.

Leonova, Katerina I., Alfiya Safina, Elimelech Nesher, et al.. (2018). TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. eLife. 7. 31 indexed citations

4.

He, Shen, Nuo Yang, Costakis Frangou, et al.. (2015). Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome. International Journal of Biological Sciences. 11(12). 1363–1375. 32 indexed citations

5.

Frangou, Costakis, Steven G. Turowski, Mihai Merzianu, et al.. (2013). Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncology. 49(9). 893–902. 15 indexed citations

6.

Fox, Robert I., Matthias Herrmann, Costakis Frangou, et al.. (1999). Mechanism of Action for Leflunomide in Rheumatoid Arthritis. Clinical Immunology. 93(3). 198–208. 312 indexed citations

7.

Fox, Robert I., Matthias Herrmann, Costakis Frangou, et al.. (1999). How Does Leflunomide Modulate the Immune Response in Rheumatoid Arthritis?. BioDrugs. 12(4). 301–315. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact